Project Grant HT94252310869
Award Date
9/30/23
Completion Date
9/29/27
Dollars Obligated
$3.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Austin, TX 78712, USA
Similar Awards
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
This federal Project Grant award, titled "Increasing Access to Evidenced-Based PTSD Treatment in the Military: Behavioral Health Technician-Delivered Written Exposure Therapy", is funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $2,398,281 grant, with a performance period from September 1, 2024 to August 31, 2028, supports research to increase access to evidence-based PTSD treatment for service members and veterans...
The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...
This Project Grant award of $3,024,846.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding a cluster randomized controlled trial of the X-CORE sexual assault prevention intervention for active-duty Airmen. The project will be conducted by the University of Texas Health Science Center at Houston (UTHealth) from September 1, 2023 through August 31, 2027. The goal is to evaluate the effectiveness of this multilevel sexual assault prevention...
This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,326,715 to the Boston VA Research Institute, Inc. (BVARI) to develop and conduct a preliminary evaluation of a self-directed, internet-based Cognitive Processing Therapy (CPT) intervention. The funding period is from September 1, 2024 to August 31, 2028. The key products and services to be delivered under this grant include: Developing the web-based CPT...
This federal Project Grant award of $6,381,198 from the Defense Health Agency was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on August 1, 2024. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports a range of biomedical research initiatives to improve health outcomes for military personnel, veterans, and the public. The "GET BETTER TOGETHER: A PRIMARY PREVENTION INTERVENTION FOR MILITARY...
The federal Project Grant award, ID HT94252410512, in the amount of $1,008,313.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader...
The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
This $5,024,305 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to augment Cognitive Processing Therapy (CPT) to prevent suicide risk among patients with PTSD. The grant was awarded to The Ohio State University on June 15, 2024 with a completion date of June 14, 2028. The project includes a sub-award to the University of Texas Health Science Center at San Antonio (UTHSCSA) to leverage the resources of the...